Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2012 Jul 21;3(12):950–961. doi: 10.1007/s13238-012-2056-z

Structural basis of heparan sulfate-specific degradation by heparinase III

Wei Dong 1, Weiqin Lu 2,3, Wallace L McKeehan 2, Yongde Luo 2, Sheng Ye 1,✉
PMCID: PMC4875378  PMID: 23011846

Abstract

Heparinase III (HepIII) is a 73-kDa polysaccharide lyase (PL) that degrades the heparan sulfate (HS) polysaccharides at sulfate-rare regions, which are important co-factors for a vast array of functional distinct proteins including the well-characterized antithrombin and the FGF/FGFR signal transduction system. It functions in cleaving metazoan heparan sulfate (HS) and providing carbon, nitrogen and sulfate sources for host microorganisms. It has long been used to deduce the structure of HS and heparin motifs; however, the structure of its own is unknown. Here we report the crystal structure of the HepIII from Bacteroides thetaiotaomicron at a resolution of 1.6 Å. The overall architecture of HepIII belongs to the (α/α)5 toroid subclass with an N-terminal toroid-like domain and a C-terminal β-sandwich domain. Analysis of this high-resolution structure allows us to identify a potential HS substrate binding site in a tunnel between the two domains. A tetrasaccharide substrate bound model suggests an elimination mechanism in the HS degradation. Asn260 and His464 neutralize the carboxylic group, whereas Tyr314 serves both as a general base in C-5 proton abstraction, and a general acid in a proton donation to reconstitute the terminal hydroxyl group, respectively. The structure of HepIII and the proposed reaction model provide a molecular basis for its potential practical utilization and the mechanism of its eliminative degradation for HS polysaccarides.

Keywords: heparinase III, crystal structure, heparan sulfate, fibroblast growth factor (FGF), β-elimination

Contributor Information

Yongde Luo, Email: yluo@ibt.tamhsc.edu.

Sheng Ye, Email: sye@zju.edu.cn.

References

  1. Bornemann D.J., Duncan J.E., Staatz W., Selleck S., Warrior R. Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways. Development. 2004;131:1927–1938. doi: 10.1242/dev.01061. [DOI] [PubMed] [Google Scholar]
  2. Bulow H.E., Hobert O. The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol. 2006;22:375–407. doi: 10.1146/annurev.cellbio.22.010605.093433. [DOI] [PubMed] [Google Scholar]
  3. Cantarel B.L., Coutinho P.M., Rancurel C., Bernard T., Lombard V., Henrissat B. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res. 2009;37:D233–238. doi: 10.1093/nar/gkn663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Capila I., Linhardt R.J. Heparin-protein interactions. Angew Chem Int Ed Engl. 2002;41:391–412. doi: 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  5. CCP4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994;50:760–763. doi: 10.1107/S0907444994003112. [DOI] [PubMed] [Google Scholar]
  6. Davies G.J., Wilson K.S., Henrissat B. Nomenclature for sugar-binding subsites in glycosyl hydrolases. Biochem J. 1997;321(Pt2):557–559. doi: 10.1042/bj3210557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Desai U.R., Wang H.M., Linhardt R.J. Specificity studies on the heparin lyases from Flavobacterium heparinum. Biochemistry. 1993;32:8140–8145. doi: 10.1021/bi00083a012. [DOI] [PubMed] [Google Scholar]
  8. Desai U.R., Wang H.M., Linhardt R.J. Substrate specificity of the heparin lyases from Flavobacterium heparinum. Arch Biochem Biophys. 1993;306:461–468. doi: 10.1006/abbi.1993.1538. [DOI] [PubMed] [Google Scholar]
  9. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  10. Ernst S., Langer R., Cooney C.L., Sasisekharan R. Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol. 1995;30:387–444. doi: 10.3109/10409239509083490. [DOI] [PubMed] [Google Scholar]
  11. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 2002;71:435–471. doi: 10.1146/annurev.biochem.71.110601.135458. [DOI] [PubMed] [Google Scholar]
  12. Godavarti R., Sasisekharan R. A comparative analysis of the primary sequences and characteristics of heparinases I, II, and III from Flavobacterium heparinum. Biochem Biophys Res Commun. 1996;229:770–777. doi: 10.1006/bbrc.1996.1879. [DOI] [PubMed] [Google Scholar]
  13. Guimond S.E., Turnbull J.E. Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides. Curr Biol. 1999;9:1343–1346. doi: 10.1016/S0960-9822(00)80060-3. [DOI] [PubMed] [Google Scholar]
  14. Han C., Belenkaya T.Y., Khodoun M., Tauchi M., Lin X. Distinct and collaborative roles of Drosophila EXT family proteins in morphogen signalling and gradient formation. Development. 2004;131:1563–1575. doi: 10.1242/dev.01051. [DOI] [PubMed] [Google Scholar]
  15. Han Y.H., Garron M.L., Kim H.Y., Kim W.S., Zhang Z., Ryu K.S., Shaya D., Xiao Z., Cheong C., Kim Y.S., et al. Structural snapshots of heparin depolymerization by heparin lyase I. J Biol Chem. 2009;284:34019–34027. doi: 10.1074/jbc.M109.025338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harmer N.J. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans. 2006;34:442–445. doi: 10.1042/BST0340442. [DOI] [PubMed] [Google Scholar]
  17. Jackson R.L., Busch S.J., Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991;71:481–539. doi: 10.1152/physrev.1991.71.2.481. [DOI] [PubMed] [Google Scholar]
  18. Kamimura K., Koyama T., Habuchi H., Ueda R., Masu M., Kimata K., Nakato H. Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling. J Cell Biol. 2006;174:773–778. doi: 10.1083/jcb.200603129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kan M., Wang F., Xu J., Crabb J.W., Hou J., McKeehan W.L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science. 1993;259:1918–1921. doi: 10.1126/science.8456318. [DOI] [PubMed] [Google Scholar]
  20. Kan M., Wu X., Wang F., McKeehan W.L. Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J Biol Chem. 1999;274:15947–15952. doi: 10.1074/jbc.274.22.15947. [DOI] [PubMed] [Google Scholar]
  21. Kjellen L., Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem. 1991;60:443–475. doi: 10.1146/annurev.bi.60.070191.002303. [DOI] [PubMed] [Google Scholar]
  22. Kussie P.H., Hulmes J.D., Ludwig D.L., Patel S., Navarro E.C., Seddon A.P., Giorgio N.A., Bohlen P. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun. 1999;261:183–187. doi: 10.1006/bbrc.1999.0962. [DOI] [PubMed] [Google Scholar]
  23. Lamanna W.C., Frese M.A., Balleininger M., Dierks T. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem. 2008;283:27724–27735. doi: 10.1074/jbc.M802130200. [DOI] [PubMed] [Google Scholar]
  24. Linhardt R.J., Galliher P.M., Cooney C.L. Polysaccharide lyases. Appl Biochem Biotechnol. 1986;12:135–176. doi: 10.1007/BF02798420. [DOI] [PubMed] [Google Scholar]
  25. Linhardt R.J., Turnbull J.E., Wang H.M., Loganathan D., Gallagher J.T. Examination of the substrate specificity of heparin and heparan sulfate lyases. Biochemistry. 1990;29:2611–2617. doi: 10.1021/bi00462a026. [DOI] [PubMed] [Google Scholar]
  26. Lohse D.L., Linhardt R.J. Purification and characterization of heparin lyases from Flavobacterium heparinum. J Biol Chem. 1992;267:24347–24355. [PubMed] [Google Scholar]
  27. Lunin V.V., Li Y., Linhardt R.J., Miyazono H., Kyogashima M., Kaneko T., Bell A.W., Cygler M. High-resolution crystal structure of Arthrobacter aurescens chondroitin AC lyase: an enzyme-substrate complex defines the catalytic mechanism. J Mol Biol. 2004;337:367–386. doi: 10.1016/j.jmb.2003.12.071. [DOI] [PubMed] [Google Scholar]
  28. Luo Y., Huang X., McKeehan W.L. High yield, purity and activity of soluble recombinant Bacteroides thetaiotaomicron GST-heparinase I from Escherichia coli. Arch Biochem Biophys. 2007;460:17–24. doi: 10.1016/j.abb.2007.01.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Luo Y., Ye S., Kan M., McKeehan W.L. Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs. J Biol Chem. 2006;281:21052–21061. doi: 10.1074/jbc.M601559200. [DOI] [PubMed] [Google Scholar]
  30. Maccarana M., Sakura Y., Tawada A., Yoshida K., Lindahl U. Domain structure of heparan sulfates from bovine organs. J Biol Chem. 1996;271:17804–17810. doi: 10.1074/jbc.271.30.17804. [DOI] [PubMed] [Google Scholar]
  31. Mayans O., Scott M., Connerton I., Gravesen T., Benen J., Visser J., Pickersgill R., Jenkins J. Two crystal structures of pectin lyase A from Aspergillus reveal a pH driven conformational change and striking divergence in the substrate-binding clefts of pectin and pectate lyases. Structure. 1997;5:677–689. doi: 10.1016/S0969-2126(97)00222-0. [DOI] [PubMed] [Google Scholar]
  32. McCarter J.D., Withers S.G. Mechanisms of enzymatic glycoside hydrolysis. Curr Opin Struct Biol. 1994;4:885–892. doi: 10.1016/0959-440X(94)90271-2. [DOI] [PubMed] [Google Scholar]
  33. Moffat C.F., McLean M.W., Long W.F., Williamson F.B. Heparinase II from Flavobacterium heparinum. Action on chemically modified heparins. Eur J Biochem. 1991;197:449–459. doi: 10.1111/j.1432-1033.1991.tb15931.x. [DOI] [PubMed] [Google Scholar]
  34. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997;53:240–255. doi: 10.1107/S0907444996012255. [DOI] [PubMed] [Google Scholar]
  35. Nader H.B., Porcionatto M.A., Tersariol I.L., Pinhal M.A., Oliveira F.W., Moraes C.T., Dietrich C.P. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. J Biol Chem. 1990;265:16807–16813. [PubMed] [Google Scholar]
  36. Otwinowski, Z., Minor, W., and Charles W. Carter, Jr. (1997). Processing of X-ray diffraction data collected in oscillation mode. In Methods in Enzymology (Academic Press), pp. 307–326. [DOI] [PubMed]
  37. Perrimon N., Bernfield M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature. 2000;404:725–728. doi: 10.1038/35008000. [DOI] [PubMed] [Google Scholar]
  38. Peter G. Alginate-modifying enzymes: A proposed unified mechanism of action for the lyases and epimerases. FEBS Letters. 1987;212:199–202. doi: 10.1016/0014-5793(87)81344-3. [DOI] [Google Scholar]
  39. Rapraeger A.C., Krufka A., Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 1991;252:1705–1708. doi: 10.1126/science.1646484. [DOI] [PubMed] [Google Scholar]
  40. Ren L., Qin X., Cao X., Wang L., Bai F., Bai G., Shen Y. Structural insight into substrate specificity of human intestinal maltase-glucoamylase. Protein Cell. 2011;2:827–836. doi: 10.1007/s13238-011-1105-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sasisekharan R., Moses M.A., Nugent M.A., Cooney C.L., Langer R. Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A. 1994;91:1524–1528. doi: 10.1073/pnas.91.4.1524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sasisekharan R., Venkataraman G. Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol. 2000;4:626–631. doi: 10.1016/S1367-5931(00)00145-9. [DOI] [PubMed] [Google Scholar]
  43. Schneider T.R., Sheldrick G.M. Substructure solution with SHELXD. Acta Crystallogr D Biol Crystallogr. 2002;58:1772–1779. doi: 10.1107/S0907444902011678. [DOI] [PubMed] [Google Scholar]
  44. Shaya D., Tocilj A., Li Y., Myette J., Venkataraman G., Sasisekharan R., Cygler M. Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J Biol Chem. 2006;281:15525–15535. doi: 10.1074/jbc.M512055200. [DOI] [PubMed] [Google Scholar]
  45. Shaya D., Zhao W., Garron M.L., Xiao Z., Cui Q., Zhang Z., Sulea T., Linhardt R.J., Cygler M. Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate. J Biol Chem. 2010;285:20051–20061. doi: 10.1074/jbc.M110.101071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sugahara K., Kitagawa H. Heparin and heparan sulfate biosynthesis. IUBMB Life. 2002;54:163–175. doi: 10.1080/15216540214928. [DOI] [PubMed] [Google Scholar]
  47. Takei Y., Ozawa Y., Sato M., Watanabe A., Tabata T. Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development. 2004;131:73–82. doi: 10.1242/dev.00913. [DOI] [PubMed] [Google Scholar]
  48. Toyoshima M., Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem. 1999;274:24153–24160. doi: 10.1074/jbc.274.34.24153. [DOI] [PubMed] [Google Scholar]
  49. Yayon A., Klagsbrun M., Esko J.D., Leder P., Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991;64:841–848. doi: 10.1016/0092-8674(91)90512-W. [DOI] [PubMed] [Google Scholar]
  50. Ye S., Luo Y., Lu W., Jones R.B., Linhardt R.J., Capila I., Toida T., Kan M., Pelletier H., McKeehan W.L. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry. 2001;40:14429–14439. doi: 10.1021/bi011000u. [DOI] [PubMed] [Google Scholar]
  51. Yip V.L., Withers S.G. Nature’s many mechanisms for the degradation of oligosaccharides. Org Biomol Chem. 2004;2:2707–2713. doi: 10.1039/b408880h. [DOI] [PubMed] [Google Scholar]
  52. Zhang F., Zhang Z., Lin X., Beenken A., Eliseenkova A.V., Mohammadi M., Linhardt R.J. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes. Biochemistry. 2009;48:8379–8386. doi: 10.1021/bi9006379. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES